Drugs / AmnioExCel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02929056 | Feb 2017 → Sep 2018 | ulcer of lower limbs, venous insufficiency | Prisma Health-Upstate | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AmnioExCel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02929056 ↗ |
| Modality | Other / unclassified | “AmnioExCel™ is a human cellular and tissue based product” NCT02929056 ↗ |